Last update 19 Sep 2024
ARMGO Pharma, Inc.

ARMGO Pharma, Inc.

Holding Company|
2004|
New York, United States
|
10-50
|

Overview

Basic Info

Introduction
ARMGO Pharma is a biopharmaceutical corporation that focuses on developing small-molecule therapies for treating various debilitating conditions such as cardiac, skeletal muscular, and neurological disorders. Their primary product, rycals, are calcium release channel stabilizers that target the ryanodine receptor/calcium release channel located on the sarcoplasmic/endoplasmic reticulum of the cell. These rycals are used in the treatment of chronic heart failure, cardiac arrythmias, muscle disorders, cognitive disorders, malignant hyperthermia, diabetes, chronic obstructive pulmonary disease, high blood pressure, and bladder dysfunction. The company was established in 2004 and has offices in Tarrytown and New York City, New York.

Tags

Cardiovascular Diseases
Nervous System Diseases
Congenital Disorders
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases1
Top 5 Drug TypeCount
Small molecule drug2
Top 5 TargetCount
RyR(Ryanodine receptors)2

Corporation Tree

Boost your research with our corporation tree data.
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 03 Oct 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 2 Clinical
2
1
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Surlorian
( RyR )
Ventricular Arrhythmia
More
Phase 2
Aladorian
( RyR )
Heart Failure
More
Phase 2
S-107
( RYR1 )
Bulbo-Spinal Atrophy, X-Linked
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free